Megan Brooks

How does regular consumption of coffee, tea, alcohol, and soda affect stroke risk? Here’s the latest data to help guide discussions with your patients.

Methadone has been shown to be highly effective for opioid use disorder. So why is it still so hard to prescribe in the United States and is that about to change?

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.

Lumryz is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in children as young as 7 years with narcolepsy.

A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of cognitive decline in older adults.

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should you know about the drug's history…and promise?

The benefits of bariatric surgery on obesity-related cancer and cardiovascular disease seen in younger adults may not translate to older adults, a population-based cohort study concluded.

Researchers have published clinical criteria for a type of memory loss in older adults that progresses more slowly and has a better prognosis than Alzheimer’s disease.

Tattoo ink tested from different manufacturers are contaminated with aerobic and anaerobic bacteria, including possibly pathogenic microorganisms, warn investigators.

The FDA has approved the anti-amyloid donanemab for early symptomatic Alzheimer’s, which includes MCI or mild dementia stage of disease, with confirmed amyloid pathology.